Key result
Fecal microbiota transplantation mitigates doxorubicin-induced cardiotoxicity via gut metabolite-driven mitochondrial protection.
Why the study?
The application of fecal microbiota transplantation in cardiovascular disease and its molecular mechanisms in protecting against doxorubicin-induced cardiotoxicity are poorly understood.
Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates that fecal microbiota transplantation reduces doxorubicin cardiotoxicity in mice, suggesting gut-heart axis modulation preserves mitochondrial health.
Aims:The relationship between the gut microbiota and cardiovascular system has been increasingly clarified. Fecal microbiota transplantation (FMT), used to improve gut microbiota, has been applied clinically for disease treatment and has great potential in combating doxorubicin (DOX)-induced cardiotoxicity. However, the application of FMT in the cardiovascular field and its molecular mechanisms are poorly understood. Results:During DOX-induced stress, FMT alters the gut microbiota and serum metabolites, leading to a reduction in cardiac injury. Correlation analysis indicated a close association between serum metabolite indole-3-propionic acid (IPA) and cardiac function. FMT and IPA achieve this by facilitating the translocation of Nfe2l2 (Nrf2) from the cytoplasm to the nucleus, thereby activating the expression of antioxidant molecules, reducing reactive oxygen species production, and inhibiting excessive mitochondrial fission. Consequently, mitochondrial function is preserved, leading to the mitigation of cardiac injury under DOX-induced stress. Innovation:FMT has the ability to modify the composition of the gut microbiota, providing not only protection to the intestinal mucosa but also influencing the generation of serum metabolites and regulating the Nrf2 gene to modulate the balance of cardiac mitochondrial fission and fusion. This study comprehensively demonstrates the efficacy of FMT in countering DOX-induced myocardial damage and elucidates the pathways linking the microbiota and the heart. Conclusion:FMT alters the gut microbiota and serum metabolites of recipient mice, promoting nuclear translocation of Nrf2 and subsequent activation of downstream antioxidant molecule expression, while inhibiting excessive mitochondrial fission to preserve cardiac integrity. Correlation analysis highlights IPA as a key contributor among differentially regulated metabolites.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2023) studied Doxorubicin-induced cardiac toxicity. Fecal microbiota transplantation (FMT) vs. No FMT (DOX-induced stress alone) was evaluated on Cardiac injury and mitochondrial function. Fecal microbiota transplantation mitigated doxorubicin-induced cardiac toxicity in mice by promoting Nrf2 nuclear translocation and inhibiting excessive mitochondrial fission via the metabolite indole-3-propionic acid.
Synapse has enriched 10 related papers. Consider them for comparative context: